» Articles » PMID: 38473328

Photodynamic Therapy and Adaptive Immunity Induced by Reactive Oxygen Species: Recent Reports

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Mar 13
PMID 38473328
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is one of the most significant causes of death worldwide. Despite the rapid development of modern forms of therapy, results are still unsatisfactory. The prognosis is further worsened by the ability of cancer cells to metastasize. Thus, more effective forms of therapy, such as photodynamic therapy, are constantly being developed. The photodynamic therapeutic regimen involves administering a photosensitizer that selectively accumulates in tumor cells or is present in tumor vasculature prior to irradiation with light at a wavelength corresponding to the photosensitizer absorbance, leading to the generation of reactive oxygen species. Reactive oxygen species are responsible for the direct and indirect destruction of cancer cells. Photodynamically induced local inflammation has been shown to have the ability to activate an adaptive immune system response resulting in the destruction of tumor lesions and the creation of an immune memory. This paper focuses on presenting the latest scientific reports on the specific immune response activated by photodynamic therapy. We present newly discovered mechanisms for the induction of the adaptive response by analyzing its various stages, and the possible difficulties in generating it. We also present the results of research over the past 10 years that have focused on improving the immunological efficacy of photodynamic therapy for improved cancer therapy.

Citing Articles

Hypericin-Mediated Photodynamic Therapy for Head and Neck Cancers: A Systematic Review.

Fiegler-Rudol J, Zieba N, Turski R, Misiolek M, Wiench R Biomedicines. 2025; 13(1).

PMID: 39857765 PMC: 11759840. DOI: 10.3390/biomedicines13010181.


One Change, Many Benefits: A Glycine-Modified Bacteriochlorin with NIR Absorption and a Type I Photochemical Mechanism for Versatile Photodynamic Therapy.

Werlos M, Barzowska-Gogola A, Pucelik B, Repetowski P, Warszynska M, Dabrowski J Int J Mol Sci. 2024; 25(23).

PMID: 39684841 PMC: 11641832. DOI: 10.3390/ijms252313132.


Viral-Porphyrin Combo: Photodynamic and Oncolytic Viral Therapy for Potent Glioblastoma Treatment.

Nazarenko A, Shkirdova A, Orlova E, Biryukova Y, Vorovitch M, Kolyasnikova N Int J Mol Sci. 2024; 25(23).

PMID: 39684289 PMC: 11640982. DOI: 10.3390/ijms252312578.


Microneedle System Coated with Hydrogels Containing Protoporphyrin IX for Potential Application in Pharmaceutical Technology.

Czarczynska-Goslinska B, Goslinski T, Roszak A, Froelich A, Szyk P, Mlynarczyk D Methods Protoc. 2024; 7(5).

PMID: 39311374 PMC: 11417702. DOI: 10.3390/mps7050073.


Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma.

Aebisher D, Woznicki P, Czarnecka-Czapczynska M, Dynarowicz K, Szliszka E, Kawczyk-Krupka A Int J Mol Sci. 2024; 25(16).

PMID: 39201395 PMC: 11354549. DOI: 10.3390/ijms25168708.


References
1.
Lou J, Aragaki M, Bernards N, Chee T, Gregor A, Hiraishi Y . Repeated photodynamic therapy mediates the abscopal effect through multiple innate and adaptive immune responses with and without immune checkpoint therapy. Biomaterials. 2022; 292:121918. DOI: 10.1016/j.biomaterials.2022.121918. View

2.
Xu C, Sun S, Johnson T, Qi R, Zhang S, Zhang J . The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep. 2021; 35(11):109235. DOI: 10.1016/j.celrep.2021.109235. View

3.
Nunes-Hasler P, Maschalidi S, Lippens C, Castelbou C, Bouvet S, Guido D . STIM1 promotes migration, phagosomal maturation and antigen cross-presentation in dendritic cells. Nat Commun. 2017; 8(1):1852. PMC: 5701258. DOI: 10.1038/s41467-017-01600-6. View

4.
Zhang Y, Cheung Y, K P Ng D, Fong W . Enhancement of innate and adaptive anti-tumor immunity by serum obtained from vascular photodynamic therapy-cured BALB/c mouse. Cancer Immunol Immunother. 2021; 70(11):3217-3233. PMC: 10991540. DOI: 10.1007/s00262-021-02917-4. View

5.
Oh D, Kim H, Oh J, Jung H, Lee Y, Park J . Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses. Oncotarget. 2017; 8(29):47440-47453. PMC: 5564577. DOI: 10.18632/oncotarget.17663. View